SNAI1 and liver cancer: For example, Nagai et al. [69] have demonstrated that sorafenib is able to suppress hepatocyte growth factor-induced liver cancer cell EMT by downregulation of Snail expression through blockage of the RAS/RAF/MEK signaling pathway.